A detailed history of Surevest, LLC transactions in Organon & Co. stock. As of the latest transaction made, Surevest, LLC holds 53 shares of OGN stock, worth $824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Previous 100 47.0%
Holding current value
$824
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $1,099 - $1,609
-47 Reduced 47.0%
53 $1,000
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $3,166 - $3,890
100 New
100 $3,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $1,431 - $1,849
-47 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$28.67 - $37.13 $1,347 - $1,745
47 New
47 $1,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Surevest, LLC Portfolio

Follow Surevest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Surevest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Surevest, LLC with notifications on news.